×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Pacira Appoints Frank D. Lee as Chief Executive Officer
Yahoo Finance
Transformational Leader Brings Three Decades of Global Experience in Pharmaceutical and Biotechnology Product Development and...
5 months ago
Iceberg Image Closes Pacira Drug Patent Infringement Trial
Law360
A generic drugmaker on Tuesday used imagery to argue that the information in a Pacira Biosciences Inc. painkiller patent is just the...
2 weeks ago
Pacira publishes data showing Exparel reduces opioid use
Clinical Trials Arena
Exparel gained FDA approval for the expanded label to include sciatic nerve block in the popliteal fossa following these positive results.
3 months ago
Pacira stock maintains price target with Overweight rating
Investing.com UK
On Tuesday, Piper Sandler reaffirmed an Overweight rating with a $42.00 price target on shares of Pacira Pharmaceuticals (NASDAQ:PCRX),...
15 hours ago
Medical society takes millions from company that sued it for defamation – and lost
Retraction Watch
When the American Society of Anesthesiologists last October announced the receipt of a $2.5 million donation from a drug company – “to...
2 months ago
Nephron faces lawsuit over pain med competitor says it sold without FDA approval
The State
Lexington County-based Nephron Pharmaceuticals is being sued by another drug manufacturer, which claims Nephron products are being marketed...
5 months ago
Pacira Touts Stability Upgrade In Pain Drug Patent Trial
Law360
A novel manufacturing process that extends the shelf life of the pain reliever Exparel should extend the exclusivity period of the product's...
3 months ago
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
Yahoo Finance
Record revenues of $675 million in 2023 — — Full-year GAAP net income of $42 million and adjusted EBITDA of $214 million — — EXPAREL...
2 months ago
LLY: Top 4 Pharma Picks for January 2024 Growth
StockNews.com
Eli Lilly and Company(NYSE:LLY): The pharmaceutical industry's future is increasingly promising, spurred by a rise in healthcare expenditure...
4 months ago
Chris Christie Blasts Pharma Ads. He Gets Paid by a Company That Runs Them
Bloomberg
Chris Christie unleashed a two-minute rant against televised drug ads in announcing his bid for the 2024 Republican presidential nomination...
11 months ago